Literature DB >> 9630260

MRI brain changes in subjects with Down syndrome with and without dementia.

G D Pearlson1, S N Breiter, E H Aylward, A C Warren, M Grygorcewicz, S Frangou, P E Barta, M B Pulsifer.   

Abstract

Individuals with Down syndrome (DS), a disorder of known genetic etiology (trisomy of chromosome 21), exhibit several types of structural brain abnormalities that are detectable pathologically and by MRI. In addition, in middle age, individuals with DS develop histological and, in some cases, clinical features of Alzheimer's disease (AD). Abnormalities in MRI scans of 50 adults with DS, 11 of whom had clinical dementia, are described and compared with those of 23 cognitively normal, healthy subjects who were matched for age, sex, and race. Qualitative visual analogue scale (VAS) ratings on MRI hard copies for all subjects and computer-aided volume measures for a subsample of subjects were carried out. On VAS, subjects with DS had larger lateral ventricles, a higher frequency of posterior fossa arachnoid cysts/megacisterna magna and fewer scans rated as normal compared with controls. Quantitatively, total brain and gray-matter volumes were reduced in DS, as were the volumes of the left hippocampus and amygdala; ventricle volumes were larger. Post hoc comparisons of subjects with DS with and without dementia revealed that on VAS the former had more generalized atrophy for age, mesial temporal shrinkage, and third ventricular enlargement. Similarly, total brain, left hippocampus, and left amygdala volumes were reduced quantitatively in subjects with DS with dementia, while ventricular volumes were increased.

Entities:  

Mesh:

Year:  1998        PMID: 9630260

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  22 in total

1.  Neuroimaging of individuals with Down's syndrome at-risk for dementia: evidence for possible compensatory events.

Authors:  R J Haier; K Head; E Head; I T Lott
Journal:  Neuroimage       Date:  2007-10-12       Impact factor: 6.556

2.  Quantitative MRI Analyses of Regional Brain Growth in Living Fetuses with Down Syndrome.

Authors:  Tomo Tarui; Kiho Im; Neel Madan; Rajeevi Madankumar; Brian G Skotko; Allie Schwartz; Christianne Sharr; Steven J Ralston; Rie Kitano; Shizuko Akiyama; Hyuk Jin Yun; Ellen Grant; Diana W Bianchi
Journal:  Cereb Cortex       Date:  2020-01-10       Impact factor: 5.357

3.  Down syndrome is accompanied by significantly reduced cortical grey-white matter tissue contrast.

Authors:  Anke Bletsch; Caroline Mann; Derek S Andrews; Eileen Daly; Giles M Y Tan; Declan G M Murphy; Christine Ecker
Journal:  Hum Brain Mapp       Date:  2018-06-08       Impact factor: 5.038

4.  The RNA-binding protein, ZC3H14, is required for proper poly(A) tail length control, expression of synaptic proteins, and brain function in mice.

Authors:  Jennifer Rha; Stephanie K Jones; Jonathan Fidler; Ayan Banerjee; Sara W Leung; Kevin J Morris; Jennifer C Wong; George Andrew S Inglis; Lindsey Shapiro; Qiudong Deng; Alicia A Cutler; Adam M Hanif; Machelle T Pardue; Ashleigh Schaffer; Nicholas T Seyfried; Kenneth H Moberg; Gary J Bassell; Andrew Escayg; Paul S García; Anita H Corbett
Journal:  Hum Mol Genet       Date:  2017-10-01       Impact factor: 6.150

Review 5.  Hippocampal deficits in neurodevelopmental disorders.

Authors:  Yue Li; Minjie Shen; Michael E Stockton; Xinyu Zhao
Journal:  Neurobiol Learn Mem       Date:  2018-10-12       Impact factor: 2.877

6.  Differential effects of trisomy on brain shape and volume in related aneuploid mouse models.

Authors:  Kristina Aldridge; Roger H Reeves; Lisa E Olson; Joan T Richtsmeier
Journal:  Am J Med Genet A       Date:  2007-05-15       Impact factor: 2.802

7.  Dissociations in Cortical Morphometry in Youth with Down Syndrome: Evidence for Reduced Surface Area but Increased Thickness.

Authors:  Nancy Raitano Lee; Elizabeth I Adeyemi; Amy Lin; Liv S Clasen; François M Lalonde; Ellen Condon; David I Driver; Philip Shaw; Nitin Gogtay; Armin Raznahan; Jay N Giedd
Journal:  Cereb Cortex       Date:  2015-06-17       Impact factor: 5.357

8.  Structural brain abnormalities in patients with schizophrenia and 22q11 deletion syndrome.

Authors:  Eva W C Chow; Robert B Zipursky; David J Mikulis; Anne S Bassett
Journal:  Biol Psychiatry       Date:  2002-02-01       Impact factor: 13.382

9.  Abnormal expression of synaptic proteins and neurotrophin-3 in the Down syndrome mouse model Ts65Dn.

Authors:  G Pollonini; V Gao; A Rabe; S Palminiello; G Albertini; C M Alberini
Journal:  Neuroscience       Date:  2008-07-25       Impact factor: 3.590

10.  Whole-brain voxel-based morphometry study of children and adolescents with Down syndrome.

Authors:  Filippo Carducci; Paolo Onorati; Claudia Condoluci; Giancarlo Di Gennaro; Pier Paolo Quarato; Alberto Pierallini; Marco Sarà; Silvia Miano; Riccardo Cornia; Giorgio Albertini
Journal:  Funct Neurol       Date:  2013 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.